common wart
Information
- Disease name
- common wart
- Disease ID
- DOID:11165
- Description
- "A viral infectious disease that results_in infection located_in skin, has_material_basis_in human papillomavirus (types 2 and 4). This infection is characterized by a raised wart with roughened surface, most common on hands, but can grow anywhere on the body." [url:http\://en.wikipedia.org/wiki/Wart]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05896215 | Active, not recruiting | Phase 2 | OM202JP Clinical Study of KNP2002 | June 12, 2023 | May 31, 2024 |
| NCT03183765 | Completed | Phase 4 | Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts | August 1, 2017 | May 1, 2018 |
| NCT03210337 | Completed | Phase 2 | A Phase2 of A-101 Topical Solution in Subjects With Common Warts | August 1, 2017 | March 16, 2018 |
| NCT03278028 | Completed | Phase 2 | A Study of A-101 Topical Solution Administered Twice a Week in Subjects With Common Warts | July 13, 2017 | March 1, 2018 |
| NCT03487549 | Completed | Phase 2 | Cantharidin and Occlusion in Verruca Epithelium | March 27, 2018 | July 15, 2019 |
| NCT03687372 | Completed | Phase 3 | Study of A-101 Topical Solution for the Treatment of Common Warts | September 17, 2018 | September 6, 2019 |
| NCT03691831 | Completed | Phase 3 | A Study of A-101 Topical Solution for the Treatment of Common Warts | September 13, 2018 | July 9, 2019 |
| NCT03812510 | Completed | Phase 3 | Safety Study of A-101 Topical Solution for the Treatment of Common Warts | February 7, 2019 | December 20, 2019 |
| NCT00328991 | Completed | N/A | Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts | October 2004 | December 2005 |
| NCT05115669 | Completed | N/A | Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts | October 12, 2021 | May 1, 2022 |
| NCT06214559 | Recruiting | N/A | Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts. | February 19, 2024 | April 2024 |
| NCT05799157 | Recruiting | Phase 2 | Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts | February 28, 2023 | December 2024 |
| NCT03977753 | Recruiting | Phase 4 | Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts | February 17, 2020 | March 16, 2024 |
| NCT01796795 | Suspended | Phase 2 | Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients | September 2030 | August 2033 |
| NCT04288817 | Unknown status | Phase 3 | Efficacy of Cryotherapy Combined With Intralesional Tuberculin PPD Versus Intralesional Tuberculin PPD in Treatment of Multiple Common Warts | March 1, 2020 | May 1, 2021 |
- Disase is a (Disease Ontology)
- DOID:934
- Cross Reference ID (Disease Ontology)
- NCI:C5028
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:30285000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0043037